Skip to main content
. 2010 Nov 18;26(5):993–1001. doi: 10.1002/jbmr.288

Table 1.

Characteristics of Propensity Score–Matched Study Population in 12 Months Prior to Filling Their First Osteoporosis Drug Prescription

Bisphosphonates Raloxifene/calcitonin
n 17,028 16,787
Demographic factors
 Age, years, mean (SD) 79.9 (6.5) 80.0 (6.9)
 Race, white 16,180 (95) 15,987 (95.2)
 Sex, female 16,474 (96.8) 16,244 (96.8)
Health care utilization
 No. of visits, mean (SD) 10.6 (6) 10.5 (6.1)
 ER visit 4,505 (26.5) 4,482 (26.7)
 No. of all prescription drugs, mean (SD) 10.4 (6) 10.5 (6.1)
 Hospitalization 6,089 (35.8) 6,146 (36.6)
 Nursing home resident 1,882 (11.1) 1,991 (11.9)
Comorbidities
 Prior fall 2,094 (12.3) 2,119 (12.6)
 Prior hip fracture 612 (3.6) 601 (3.6)
 Prior vertebral fracture 1,858 (10.9) 1,890 (11.3)
 BMD test 4,085 (24) 4,180 (24.9)
 Hypertension 11,303 (66.4) 11,233 (66.9)
 Chronic kidney disease 492 (2.9) 481 (2.9)
 Chronic liver disease 207 (1.2) 191 (1.1)
 Parkinson disease 586 (3.4) 598 (3.6)
 Dementia 1,039 (6.1) 1,092 (6.5)
 Diabetes mellitus 4,354 (25.6) 4,312 (25.7)
 Congestive heart failure 3,664 (21.5) 3,728 (22.2)
 Chronic obstructive pulmonary disease (COPD) 4,782 (28.1) 4,763 (28.4)
 Inflammatory arthritis 1,267 (7.4) 1,258 (7.5)
 Inflammatory bowel disease 241 (1.4) 226 (1.4)
 Alcoholism 311 (1.8) 301 (1.8)
 Comorbidity index, mean (SD) 1.9 (1.9) 2 (1.9)
Other medications
 Opioids 6,817 (40) 6,826 (40.7)
 Antiepileptics 892 (5.2) 877 (5.2)
 Proton pump inhibitors 4,361 (25.6) 4,441 (26.5)
 Benzodiazepines 4,636 (27.2) 4,614 (27.5)
 Selective serotonin reuptake inhibitors (SSRIs) 2,654 (15.6) 2,683 (16)
 Warfarin 1,814 (10.7) 1,786 (10.6)
 Inhaled steroid 1,389 (8.2) 1,391 (8.3)
 Oral steroid 2,420 (14.2) 2,387 (14.2)

Note: New Jersey and Pennsylvania combined, second drug dispensing and a 90-day lag period are required. Data are presented in number (%), unless specified.

SD = standard deviation; ER = emergency room; BMD = bone mineral density.